Related Experiment Video

Updated: Aug 14, 2026

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients

A G Chandorkar, N P Burte, J H Jadhav

    Indian Journal of Leprosy
    |April 1, 1984
    PubMed

    Insights

    Thalidomide effectively controlled erythema nodosum leprosum (ENL) reactions in leprosy patients within 18 days. This treatment did not alter bacteriological status or affect organ functions, showing a favorable safety profile.

    Area of Science:

    • Immunology
    • Dermatology
    • Infectious Diseases

    Background:

    • Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
    • Erythema nodosum leprosum (ENL) is a common inflammatory complication of leprosy.
    • Conventional treatments for ENL may be inadequate for some patients.

    Purpose of the Study:

    • To evaluate the efficacy and safety of thalidomide in managing ENL reactions in leprosy patients.
    • To assess the impact of thalidomide on bacteriological status and organ functions.

    Main Methods:

    • Six male patients with lepromatous leprosy and ENL were treated with thalidomide 400 mg/day.
    • Treatment duration and patient response were monitored.
    • Bacteriological status, liver function, renal function, and hemogram were assessed before and after treatment.

    Main Results:

    • Thalidomide controlled ENL reactions within 13 to 18 days of therapy.
    • No significant changes were observed in bacteriological status.
    • Liver function, renal function, and hemogram remained normal throughout the study.
    • Adverse effects were limited to fatigue, drowsiness, and occasional constipation.

    Conclusions:

    • Thalidomide is effective in controlling ENL reactions in leprosy patients.
    • The mechanism of action may involve immunosuppressive effects and lysosomal stabilization.
    • Thalidomide demonstrates a favorable safety profile for managing ENL, with no adverse impact on key physiological parameters.

    More Related Videos

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

    Published on: May 15, 2019

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Related Concept Videos

    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

    Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...